Does TAPINAROF Cause Application site erythema? 54 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 54 reports of Application site erythema have been filed in association with TAPINAROF (VTAMA). This represents 3.9% of all adverse event reports for TAPINAROF.
54
Reports of Application site erythema with TAPINAROF
3.9%
of all TAPINAROF reports
0
Deaths
3
Hospitalizations
How Dangerous Is Application site erythema From TAPINAROF?
Of the 54 reports, 3 (5.6%) required hospitalization.
Is Application site erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAPINAROF. However, 54 reports have been filed with the FAERS database.
What Other Side Effects Does TAPINAROF Cause?
Folliculitis (281)
Pruritus (165)
Headache (142)
Dermatitis contact (122)
Rash (103)
Erythema (94)
Drug ineffective (80)
Skin burning sensation (79)
Application site pruritus (54)
Application site pain (50)
What Other Drugs Cause Application site erythema?
NICOTINE (2,004)
SUMATRIPTAN (1,875)
INGENOL MEBUTATE (1,373)
BUPRENORPHINE (1,273)
ESTRADIOL (1,117)
MINOXIDIL (1,061)
METHYLPHENIDATE (543)
ESTRADIOL\NORETHINDRONE (533)
FENTANYL (501)
OXYTROL FOR WOMEN (422)
Which TAPINAROF Alternatives Have Lower Application site erythema Risk?
TAPINAROF vs TARCEVA
TAPINAROF vs TARLATAMAB
TAPINAROF vs TARLATAMAB-DLLE
TAPINAROF vs TASIGNA
TAPINAROF vs TASIMELTEON